NCAM1 and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, the level of NK cells expressing CD56 was greatly increased in CML patients on treatment with TKIs, which is in agreement with previous reports that describe NK cells as the main component of LGLs [17,55].